Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

CA Schmittinger, C Torgersen, G Luckner… - Intensive care …, 2012 - Springer
Purpose To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …
被引用次数：231 相关文章

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

C Schmittinger, CE Torgersen, G Luckner… - Intensive care …, 2012 - boris.unibe.ch
PURPOSE: To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

C Schmittinger, C Torgersen, G Luckner… - Intensive Care …, 2012 - doc.rero.ch
Purpose: To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

CA Schmittinger, C Torgersen, G Luckner… - Intensive Care …, 2012 - go.gale.com
Purpose To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …

[引用][C] Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

CA Schmittinger, C Torgersen, G Luckner… - INTENSIVE CARE …, 2012 - pure.pmu.ac.at
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational
study — PMU Research Portal Skip to main navigation Skip to search Skip to main content …

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

CA Schmittinger, C Torgersen, G Luckner… - Intensive Care …, 2012 - europepmc.org
Purpose To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

CA Schmittinger, C Torgersen, G Luckner… - Intensive care …, 2012 - sonar.ch
METHODS The occurrence of any of seven predefined adverse cardiac events (prolonged
elevated heart rate, tachyarrhythmia, myocardial cell damage, acute cardiac arrest or death …

[引用][C] Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

CA SCHMITTINGER, C TORGERSEN… - … care medicine (Print …, 2012 - pascal-francis.inist.fr
Adverse cardiac events during catecholamine vasopressor therapy: a prospective
observational study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

CA Schmittinger, C Torgersen, G Luckner… - Intensive Care …, 2012 - cir.nii.ac.jp
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational
study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

CA Schmittinger, C Torgersen… - Intensive care …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …